Holding(s) in Company

Imaginatik PLC
10 March 2008

Form TR-1 with annex. FSA Version 2.1 updated April 2007


For filings with the FSA include the annex

For filings with issuer exclude the annex


TR-1: Notifications of Major Interests in Shares
                                                             

1. Identity of the issuer or the underlying issuer of         Imaginatik Plc
existing shares to which voting rights are attached:


2. Reason for notification (yes/no)
                                                                                        

An acquisition or disposal of voting rights                       Yes


An acquisition or disposal of financial 
instruments which may result in the acquisition
of shares already issued to which voting rights are attached


An event changing the breakdown of voting rights


Other (please specify):______________
                                                     

3. Full name of person(s) subject to notification         Pfizer Inc.
obligation:
                                                    

4. Full name of shareholder(s) (if different from         Pfizer Inc.
3):
                                                     

5. Date of transaction (and date on which the             06/03/2008
threshold is crossed or reached if different):
                                                     

6. Date on which issuer notified:                         07/03/2008


7. Threshold(s) that is/are crossed or reached:           6%






8: Notified Details
A: Voting rights attached to shares


Class/type of       Situation previous to the Resulting situation after the triggering transaction
shares              triggering transaction

If possible use
ISIN code

                    Number of    Number of    Number of    Number of voting rights Percentage of voting
                    shares       voting       shares                               rights
                                 rights
                                                           Direct       Indirect   Direct     Indirect


GB00B1G2HX83        Less than   Less than     8,035,885    8,035,885               6.45%
                    3%          3%





B: Financial Instruments


Resulting situation after the triggering transaction


Type of financial    Expiration date      Exercise/ conversion No. of voting rights  Percentage of voting
instrument                                period/date          that may be acquired  rights
                                                               (if the instrument
                                                               exercised/converted)







Total (A+B)


Number of voting rights                              Percentage of voting rights
8,035,885                                            6.45%






9. Chain of controlled undertakings through which the voting rights and /or the
financial instruments are effectively held, if applicable:







Proxy Voting:


10. Name of proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:


14 Contact name:                         Roger J. Hill PhD

                                         Worldwide Business Development| Pfizer Inc.| 50 Pequot
                                         Ave.| New London CT 06320 | USA
                                         Email:  [e-mail]




15. Contact telephone name:              Roger J. Hill PhD
                                         Office: 860 732 2365;
                                         fax: [phone]







                      This information is provided by RNS
            The company news service from the London Stock Exchange